NSG 5240 Advanced Pharmacology Midterm Exam | Complete
Questions with Verified Correct Answers & Detailed Explanations
–2026/2027 Update | Graded A+
Question 1
A patient is prescribed a medication with a narrow therapeutic index. Which
nursing action is most important when administering this medication?
A. Monitor the patient closely for therapeutic and toxic effects
B. Encourage the patient to double the dose if symptoms persist
C. Assume adverse effects are unrelated to serum drug concentration
D. Discontinue laboratory monitoring once symptoms improve
Correct Answer: A. Monitor the patient closely for therapeutic and toxic
effects
Explanation:
Medications with a narrow therapeutic index have a relatively small
difference between effective and toxic concentrations. Patients receiving these
medications often require careful assessment, laboratory monitoring, dose
adjustment, and evaluation for drug interactions.
Question 2
Which pharmacokinetic process describes the movement of a drug from the
site of administration into the systemic circulation?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Correct Answer: A. Absorption
Explanation:
Absorption is the process by which a drug enters the bloodstream from its
1
,administration site. The route of administration, formulation, blood flow,
gastrointestinal function, and other factors can affect the rate and extent of
absorption.
Question 3
A medication undergoes extensive first-pass metabolism. Which route of
administration would generally avoid significant hepatic first-pass
metabolism?
A. Intravenous
B. Oral
C. Enteral feeding tube
D. Immediate-release oral tablet
Correct Answer: A. Intravenous
Explanation:
Intravenous administration delivers the drug directly into systemic
circulation and therefore bypasses gastrointestinal absorption and hepatic
first-pass metabolism. Some other nonoral routes can also bypass first-pass
metabolism, depending on the route and drug.
Question 4
A patient has severe hepatic impairment. Which pharmacokinetic process may
be significantly affected?
A. Drug metabolism
B. Medication packaging
C. Tablet color
D. Medication labeling
Correct Answer: A. Drug metabolism
Explanation:
The liver is a major site of drug metabolism. Hepatic dysfunction can reduce
2
,clearance of medications that depend heavily on hepatic metabolism,
potentially increasing drug exposure and toxicity.
Question 5
A medication has a high protein-binding affinity. Which patient condition
could increase the amount of free drug available?
A. Hypoalbuminemia
B. Increased muscle mass
C. Increased bone density
D. Hyperpigmentation
Correct Answer: A. Hypoalbuminemia
Explanation:
Many drugs bind to plasma proteins such as albumin. When albumin
concentrations are low, less drug may be protein-bound and more may
circulate in an unbound form. The free fraction is generally pharmacologically
active and available for distribution and elimination.
Question 6
Which statement best describes a medication's half-life?
A. The time required for the plasma concentration of a drug to decrease by
approximately 50%
B. The time required for a drug to begin absorption
C. The time required to reach the maximum therapeutic effect in every patient
D. The time required for complete elimination in all patients
Correct Answer: A. The time required for the plasma concentration of a
drug to decrease by approximately 50%
Explanation:
Half-life is an important pharmacokinetic parameter used to estimate drug
3
, accumulation, duration of action, and dosing intervals. The actual clinical
duration of effect may differ from the drug's plasma half-life.
Question 7
A patient taking a medication with a long half-life misses one dose. Why might
the patient still have measurable drug levels?
A. The drug is eliminated gradually over multiple half-lives
B. The drug cannot be metabolized
C. The drug is permanently stored in the stomach
D. The drug immediately converts into another active medication
Correct Answer: A. The drug is eliminated gradually over multiple half-
lives
Explanation:
Drugs with longer half-lives remain in the body for a longer period.
Elimination generally occurs progressively rather than all at once, so
measurable concentrations can remain after a missed dose.
Question 8
Which pharmacodynamic concept describes the relationship between drug
concentration and the magnitude of the pharmacologic response?
A. Dose-response relationship
B. First-pass effect
C. Renal clearance
D. Bioavailability
Correct Answer: A. Dose-response relationship
Explanation:
The dose-response relationship describes how changes in drug exposure
affect the magnitude of a response. It helps clinicians understand therapeutic
effects, potency, efficacy, and potential toxicity.
4
Questions with Verified Correct Answers & Detailed Explanations
–2026/2027 Update | Graded A+
Question 1
A patient is prescribed a medication with a narrow therapeutic index. Which
nursing action is most important when administering this medication?
A. Monitor the patient closely for therapeutic and toxic effects
B. Encourage the patient to double the dose if symptoms persist
C. Assume adverse effects are unrelated to serum drug concentration
D. Discontinue laboratory monitoring once symptoms improve
Correct Answer: A. Monitor the patient closely for therapeutic and toxic
effects
Explanation:
Medications with a narrow therapeutic index have a relatively small
difference between effective and toxic concentrations. Patients receiving these
medications often require careful assessment, laboratory monitoring, dose
adjustment, and evaluation for drug interactions.
Question 2
Which pharmacokinetic process describes the movement of a drug from the
site of administration into the systemic circulation?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Correct Answer: A. Absorption
Explanation:
Absorption is the process by which a drug enters the bloodstream from its
1
,administration site. The route of administration, formulation, blood flow,
gastrointestinal function, and other factors can affect the rate and extent of
absorption.
Question 3
A medication undergoes extensive first-pass metabolism. Which route of
administration would generally avoid significant hepatic first-pass
metabolism?
A. Intravenous
B. Oral
C. Enteral feeding tube
D. Immediate-release oral tablet
Correct Answer: A. Intravenous
Explanation:
Intravenous administration delivers the drug directly into systemic
circulation and therefore bypasses gastrointestinal absorption and hepatic
first-pass metabolism. Some other nonoral routes can also bypass first-pass
metabolism, depending on the route and drug.
Question 4
A patient has severe hepatic impairment. Which pharmacokinetic process may
be significantly affected?
A. Drug metabolism
B. Medication packaging
C. Tablet color
D. Medication labeling
Correct Answer: A. Drug metabolism
Explanation:
The liver is a major site of drug metabolism. Hepatic dysfunction can reduce
2
,clearance of medications that depend heavily on hepatic metabolism,
potentially increasing drug exposure and toxicity.
Question 5
A medication has a high protein-binding affinity. Which patient condition
could increase the amount of free drug available?
A. Hypoalbuminemia
B. Increased muscle mass
C. Increased bone density
D. Hyperpigmentation
Correct Answer: A. Hypoalbuminemia
Explanation:
Many drugs bind to plasma proteins such as albumin. When albumin
concentrations are low, less drug may be protein-bound and more may
circulate in an unbound form. The free fraction is generally pharmacologically
active and available for distribution and elimination.
Question 6
Which statement best describes a medication's half-life?
A. The time required for the plasma concentration of a drug to decrease by
approximately 50%
B. The time required for a drug to begin absorption
C. The time required to reach the maximum therapeutic effect in every patient
D. The time required for complete elimination in all patients
Correct Answer: A. The time required for the plasma concentration of a
drug to decrease by approximately 50%
Explanation:
Half-life is an important pharmacokinetic parameter used to estimate drug
3
, accumulation, duration of action, and dosing intervals. The actual clinical
duration of effect may differ from the drug's plasma half-life.
Question 7
A patient taking a medication with a long half-life misses one dose. Why might
the patient still have measurable drug levels?
A. The drug is eliminated gradually over multiple half-lives
B. The drug cannot be metabolized
C. The drug is permanently stored in the stomach
D. The drug immediately converts into another active medication
Correct Answer: A. The drug is eliminated gradually over multiple half-
lives
Explanation:
Drugs with longer half-lives remain in the body for a longer period.
Elimination generally occurs progressively rather than all at once, so
measurable concentrations can remain after a missed dose.
Question 8
Which pharmacodynamic concept describes the relationship between drug
concentration and the magnitude of the pharmacologic response?
A. Dose-response relationship
B. First-pass effect
C. Renal clearance
D. Bioavailability
Correct Answer: A. Dose-response relationship
Explanation:
The dose-response relationship describes how changes in drug exposure
affect the magnitude of a response. It helps clinicians understand therapeutic
effects, potency, efficacy, and potential toxicity.
4
